Kidney failure in cirrhosis: review of the literature
PDF (Español (España))

Keywords

acute renal failure
creatinine
liver cirrhosis
hepatorenal syndrome

How to Cite

1.
Almanza Hurtado AJ, Rodríguez Yánez T, Martínez-Ávila MC, Imbeth Acosta P. Kidney failure in cirrhosis: review of the literature. Rev. Colomb. Nefrol. [Internet]. 2022 Feb. 14 [cited 2022 May 18];9(1):e531. Available from: https://revistanefrologia.org/index.php/rcn/article/view/531

Abstract

Introduction: During the cirrhotic patient’s disease, renal failure is a poor prognostic event.

Purpose: Knowing the risk factors for AKI in these patients given by the presence of infectious processes, loss of fluids due to hemorrhage, gastrointestinal or kidney, and nephrotoxic agents are essential for initiating therapeutic measures and prophylactic actions.

Methodology: A bibliographic search was carried out in the PubMed, EMBASE, Scopus and academic Google databases, using the terms MeSH acute renal failure, creatinine, liver cirrhosis, hepatorenal syndrome. Original articles, meta-analyzes, case reports, case series and literature reviews were obtained, choosing 16 documents for the preparation of this review.

Results: The new criteria defined by the International Ascites Club (AKI-IAC), which eliminate urinary out put, are determined by an increase in serum creatinine?0.3 mg / dL in less than 48 hours and improve the prognosis, allowing timely interventions.

Conclusions: Creatinine continues to be the most widely used biomarker in AKI, even in cirrhotic patients, despite its multiple limitations. A dynamic criterion modified from the AKIN criteria becomes the gold standard for the diagnosis of AKI in cirrhosis.

https://doi.org/10.22265/acnef.9.1.531
PDF (Español (España))

References

Arroyo V, Ginès P, Gerbes AL, Dudley FJ, Gentilini P, Laffi G, et al. Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. Hepatology. 1996;23(1):164-76. https://doi.org/10.1002/hep.510230122

Sherman DS, Fish DN, Teitelbaum I. Assessing renal function in cirrhotic patients: problems and pitfalls. American journal of kidney diseases. 2003;41(2):269-78. https://doi.org/10.1053/ajkd.2003.50035

Caregaro L, Menon F, Angeli P, Amodio P, Merkel C, Bortoluzzi A, et al. Limitations of serum creatinine level and creatinine clearance as filtration markers in cirrhosis. Archives of internal medicine. 1994;154(2):201-5. https://doi.org/10.1001/archinte.1994.00420020117013

Spencer K. Analytical reviews in clinical biochemistry: the estimation of creatinine. Annals of clinical biochemistry. 1986;23(1):1-25. https://doi.org/10.1177/000456328602300101

Wong F, Nadim MK, Kellum JA, Salerno F, Bellomo R, Gerbes A,et al. Working partyproposal for a revised classication system of renal dysfunction in patients with cirrhosis.Gut. 2011:60(5):702-9. https://doi.org/10.1136/gut.2010.236133

Angeli P, Ginès P, Wong F, Bernardi M, Boyer TD, Gerbes A,et al. Diagnosis and manage-ment of acute kidney injury in patients with cirrhosis: revised consensusrecommendationsof the International Club of Ascites. J Hepatol. 2015;62(4):968-74. https://doi.org/10.1016/j.jhep.2014.12.029

Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P. Acute renal failure-denition, out-come measures, animal models, uid therapy and information technology needs: the SecondInternational Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group.Crit Care. 2004 ag;8(4):R204-12. https://doi.org/10.1186/cc2872

Kellum JA, Lameire N, Aspelin P, Barsoum RS, Burdmann EA, Goldstein SL, et al. Kidney disease: improving global outcomes (KDIGO) acute kidney injury work group. KDIGO clinical practice guideline for acute kidney injury. Kidney international supplements. 2012;2(1):1-138.

Salerno F, Gerbes A, Ginès P, Wong F, Arroyo V. Diagnosis, prevention and treatmentof hepatorenal syndrome in cirrhosis. Postgrad Med J. 2008;84(998):662-70. https://doi.org/10.1136/gut.2006.107789

Garzia P, Ferri G, Ilardi M, Messina F, Amoroso A. Pathophysiology, clinical features and management of hepatorenal syndrome. Eur Rev Med Pharmacol Sci. 1998;2(5):181-4.

Ginès P, Arroyo V, Vargas V, Planas R, Casafont F, Panés J,et al. Paracentesis withintravenous infusion of albumin as compared with peritoneovenous shunting in cirrho-sis with refractory ascites. N Engl J Med. 1991;325(12):829-35. https://doi.org/10.1056/NEJM199109193251201

Angeli P, Fasolato S, Mazza E, Okolicsanyi L, Maresio G, Velo E, Galioto A,et al. Combinedversus sequential diuretic treatment of ascites in non-azotaemic patients with cirrhosis:results of an open randomized clinical trial. Gut. 2010;59:98-104. https://doi.org/10.1136/gut.2008.176495

Angeli P, Gatta A, Caregaro L, Menon F, Sacerdoti D, Merkel C,et al. Tubular site of renalsodium retention in ascitic liver cirrhosis evaluated by lithium clearance. Eur J Clin Invest.1990;20(1):111-7. https://doi.org/10.1111/j.1365-2362.1990.tb01800.x

Joannidis M, Metnitz B, Bauer P, Schusterschitz N, Moreno R, Druml W,et al.Acute kid-ney injury in critically ill patients classied by AKIN versus RIFLE using the SAPS 3 database. Intensive Care Med. 2009;35(10):1692-702. https://doi.org/10.1007/s00134-009-1530-4

Tu KH, Jenq CC, Tsai MH, Hsu HH, Chang MY, Tian YC,et al. Outcome scoring systemsfor short-term prognosis in critically ill cirrhotic patients. Shock. 2011;36(5):445- 50. https://doi.org/10.1097/SHK.0b013e31822fb7e2

Tsien CD, Rabie R, Wong F. Acute kidney injury in decompensated cirrhosis. Gut.2013;62(1):131-7. https://doi.org/10.1136/gutjnl-2011-301255

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Downloads

Download data is not yet available.